Tarsus Pharmaceuticals TARS
NASDAQ TARS
$76.75 -0.06 (-0.08%)
As of: Sep 29, 2026 · 3:59 PM EDT

Tarsus Pharmaceuticals (TARS) EBT Margin (2021 - 2026)

Updated

Tarsus Pharmaceuticals (TARS) posted EBT Margin of -10.56% for Q2 2026, up 9.11 percentage points from -19.67% a year earlier but down 7.77 percentage points from the prior quarter.

Analysis

Tarsus Pharmaceuticals (TARS) EBT Margin (2021 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EBT Margin at Tarsus Pharmaceuticals was -6.90%, up 24.17 percentage points year-over-year; for FY2025, it was -14.26%, up 48.90 percentage points from FY2024.

  • Annual EBT Margin shows a four-year change of +9.89 percentage points (FY2021 to FY2025).
  • In prior years, Tarsus Pharmaceuticals' EBT Margin was -63.16% in FY2024 (+715.73 pp), -778.89% in FY2023 (-538.36 pp), -240.53% in FY2022 (-216.38 pp) and -24.15% in FY2021.
  • Quarterly EBT Margin has run from a low of -4274.56% in Q4 2021 to a high of -2.79% in Q1 2026 over five years.
  • On a year-over-year basis, EBT Margin has increased in each of the last eight quarters, with an average year-over-year change of +322.99 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for EBT Margin in the past five years was Q4 2022, with a gain of 4138.30 percentage points; the weakest was Q1 2022, with a drop of 3712.38 percentage points.
  • According to Business Quant data, EBT Margin for the three prior quarters was -2.79% (Q1 2026), -4.11% (Q4 2025) and -10.69% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 26.66%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 25.18%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -4.11%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 29.63%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 18.19%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 27.53%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -131.41%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -4.34%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 41.75%
10 Tarsus Pharmaceuticals 3.32 Bn 2.27 Bn 161.80 Mn -10.56%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -10.56%
Mar 31, 2026 -2.79%
Dec 31, 2025 -4.11%
Sep 30, 2025 -10.69%
Jun 30, 2025 -19.67%
Mar 31, 2025 -31.96%
Dec 31, 2024 -34.76%
Sep 30, 2024 -48.81%
Jun 30, 2024 -76.64%
Mar 31, 2024 -128.74%
Dec 31, 2023 -324.72%
Sep 30, 2023 -2,081.93%
Mar 31, 2023 -933.72%
Dec 31, 2022 -136.26%
Jun 30, 2022 -35.81%
Mar 31, 2022 -3,680.33%
Dec 31, 2021 -4,274.56%
Sep 30, 2021 -1,265.89%
Jun 30, 2021 33.07%
Mar 31, 2021 32.05%
API Access

Tarsus Pharmaceuticals EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=TARS&period=max&api_key=YOUR_API_KEY